NET PROFIT (x1000 NOK)
EMPLOYEES
Biomediq A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | -87 | -34 | 424 |
Total assets | 179 | 320 | 1,457 |
Current assets | 179 | 320 | 1,457 |
Current liabilities | 71 | 75 | 123 |
Equity capital | 81 | 160 | 1,251 |
- share capital | 603 | 566 | 536 |
Employees (average) | 7 | 7 | 7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 45.3% | 50.0% | 85.9% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 252.1% | 426.7% | 1184.6% |
Return on equity (ROE) | -107.4% | -21.2% | 33.9% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.